ELTP
ELITE PHARMACEUTICALS INC /NV/
Key Financials
Gross Profit
$40.1M
↑ 52.1%
Net Income
$-4314659
↓ 121.5%
Operating Income
$19.6M
↑ 81.7%
Revenue
$84.0M
↑ 48.4%
EPS (Diluted)
$0.00
↓ 100.0%
Total Assets
$96.4M
↑ 15.2%
Total Liabilities
$42.9M
↑ 64.4%
Shareholders' Equity
$53.5M
↓ 7.1%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | ELTP |
| Company Name | ELITE PHARMACEUTICALS INC /NV/ |
| CIK | 1053369 |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 0331 |
| State of Incorporation | NJ |
| Phone | 2017502646 |